美国食品和药物管理局批准阿斯特拉泽内卡的狼药, 每周在家用自动注射器. FDA approves AstraZeneca's lupus drug for weekly home use via autoinjector.

美国食品和药物管理局批准AstraZeneca的Saphnelo通过每周一次自动注射器进行皮下自我施用,用于患有全身性红斑狼的成年人. The FDA has approved AstraZeneca's Saphnelo for subcutaneous self-administration via a once-weekly autoinjector for adults with systemic lupus erythematosus. 这种扩展使患者能够在家中自给注射,与以前的静脉内注射要求相比改善了便利性和可用性. This expansion allows patients to self-inject at home, improving convenience and access compared to the previous intravenous requirement. 批准是在成功的试验结果显示疾病活动和安全性减少后获得的,与IV版本一致. The approval follows successful trial results showing reduced disease activity and safety consistent with the IV version.